Aprea Therapeutics (APRE) P/E (2019 - 2026)
Aprea Therapeutics (APRE) P/E from Oct 3, 2019 to Jul 21, 2026. The TTM Aprea Therapeutics (APRE) P/E is -0.40. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Aprea Therapeutics (APRE)
| Year | P/E | Change |
|---|---|---|
| 2026 | -0.40 | -3.07% |
| 2025 | -0.41 | -70.24% |
| 2024 | -1.38 | +12.47% |
| 2023 | -1.23 | +1754.31% |
| 2022 | -0.07 | -95.99% |
| 2021 | -1.65 | -15.17% |
| 2020 | -1.95 | -96.24% |
| 2019 | -51.79 | N/A |
Comparison Aprea Therapeutics (APRE) P/E with competitors
Aprea Therapeutics (APRE) P/E is -0.40.